Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Nanosonics Ltd. (ASX:NAN) Shares Could Go Gangbusters

Nanosonics Ltd. (ASX:NAN) shares could rise after NAN released its half-year results with net profit up 221% to $7.1 million.

Today Nanosonics Ltd (ASX: NAN) released their half-year results for the period ending 31 December 2018 with net profit up 221% to $7.1 million.

About Nanosonics

Nanosonics manufacturers the Trophon EPR ultrasound probe disinfector and its related consumables. Nanosonics is seen similar to the Gillette model as customers buy the Trophon EPR system (the razor), then buy consumables (blades) which are high margin and recurring.

Andrew Page from Strawman.com recently covered Nanosonics in an investors event in Melbourne, co-hosted by us at The Rask Group.

Key Results

Nanosonics reported:

  • Record first half sales up 36% to $40.7 million
  • Installed base (trophon EPR systems) up 20% to 19,310
  • Revenue up 36% to $40.7 million
    • Capital sales (trophon EPR systems) up 11% to $16.4 million
    • Consumable and service sales up 59% to $24.3 million
  • Net profit after tax (NPAT) up 221% to $7.1 million
  • Cash from operating activities of $2.56 million.

Management Commentary

CEO and President of Nanosonics Michael Kavanagh said, “the organisation has delivered a strong set of results for the first half where we continued to grow the trophon installed base, deliver record half year financial results and progress many aspects of our strategic growth priorities, including geographic expansion and new product development”.

Nanosonics released its tropon2 technology in the second half of calendar 2018, with Mr Kavanagh saying, “customer reaction to the new features and benefits of trophon2 has been very positive with increasing numbers of trophon2 being adopted over trophon EPR every month since launch”.

Geographical Expansion

The North American market makes up 17,020 of its 19,310 installed units, but the company has plans to expand further worldwide with Mr Kavanagh saying, “Our geographical expansion activities progressed  with new agreements established with GE Healthcare for distribution in Denmark, Finland, Spain and Portugal effective February 2019. This is in addition to existing agreements with GE Healthcare in Sweden and Norway. A new distributor was also appointed for Switzerland”.

Nanosonics also signed a distribution agreement for Mexico and a market assessment study has commenced for China.

Rask Perspective

Nanosonics is a company doing great things which help to prevent the spread of infection in hospitals. While I would like to add it back to my share portfolio again, I think it’s too expensive at these price levels for me to buy more shares today.

[ls_content_block id=”14947″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content